Private & Public financial sources that help developing Thrombotargets Projects:
Thrombotargets, an emergent company based on High Throughput Screening, works to create value through innovation and improved earning power. Private investors and public organizations are collaborating with Thrombotargets to turn the goals into reality.
m
Funding allows the company to invest in some core projects to increase its pipeline of new drug candidates thanks to its High Throughput Screening platform, the 
|
Private Fundings
|
|
|
Organization
|
Year
|
|
|
|
|
Biotech Angels
|
2005
|
|
Biotech Angels
|
2006
|
|
Biotech Angels
|
2007
|
|
BioLead Capital
|
2007
|
|
Biotech Angels
|
2009
|
|
BioLead Capital
|
2009
|
|
|
|
|
Public Fundings
|
|
|
Public Funding Organizations
|
|
|
|
|
Centre for the Industrial Technologic Development (CDTI)
|
|
National Innovation Company (ENISA)
|
|
Science and Education Ministry (MICINN)
|
|
Commerce, Tourism and Industry (MITYC)
|
|
Madrid Institute of Development (IMADE)
|
|
Catalan Agency for Competitiveness (ACC1Ó)
|
|
Spanish Institute of Foreign Commerce (ICEX)
Fondo Europeo de Desarrollo Regional (FEDER)
|